Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

ClinicalTrials.gov ID: NCT00104013

Public ClinicalTrials.gov record NCT00104013. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 30, 2026, 3:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess xaliproden's potential capacity of slowing the deterioration of cognitive and global functions in patients with mild to moderate Alzheimer's disease. The patients participating in this study will take orally once daily xaliproden or placebo (inactive substance pill).

Study identification

NCT ID
NCT00104013
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
1,455 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2003 (Type not available)
Primary completion
Nov 2007 (Actual)
Completion
Nov 2007 (Actual)
Last update posted
Aug 21, 2008

2003 – 2007

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Neurological Physicians of Arizona, Inc. Mesa Arizona 85201 —
Pivotal Research Centers Mesa Arizona 85210 —
Pivotal Research Centers Peoria Arizona 85381 —
Northwest NeuroSpecialists Tucson Arizona 85741-3537 —
Optimum Health Services Oceanside California 92056 —
Anderson Clinical Research Redlands California 92374 —
Univ. of CT Health Center Farmington Connecticut 06030 —
CNS Healthcare Jacksonville Florida 32216 —
Mayo Clinic Jacksonville Florida 32224 —
Renstar Medical Research Ocala Florida 34471 —
Memory Disorder Center Pompano Beach Florida 33064 —
Neurological Center Fort Wayne Indiana 46805 —
Vince and Associates Clinical Research Overland Park Kansas 66211 —
Hartford Research Group Florence Kentucky 41042 —
Lexington Clinic Lexington Kentucky 40504 —
LSUHSC Geriatric Psychiatry New Orleans Louisiana 70112 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Synergy Medical Saginaw Michigan 48602 —
University Medical Center, Dept. of Psychiatry Clinical Trials Jackson Mississippi 39216 —
Radiant Research, Inc. St Louis Missouri 63141 —
Center For Emotional Fitness Moorestown New Jersey 08057 —
Ubhc/Umdnj667 Piscataway New Jersey 08855 —
The Ohio State University Columbus Ohio 43210 —
The Clinical Trial Center Jenkintown Pennsylvania 19046 —
Radiant Research Greer South Carolina 29651 —
Alzheimer's Research & Clinical Programs North Charleston South Carolina 29406 —
Harmony Research, Inc Johnson City Tennessee 37601 —
R/D Clinical Research, Inc. Lake Jackson Texas 77566 —
Grayline Clinical Drug Trial Wichita Falls Texas 76309 —
The Innovative Clinical Research Center Alexandria Virginia 22304 —
Eastern Virginia Medical School - The Glennan Center For Geriatrics "Gerontology" Norfolk Virginia 23507 —
National Clinical Research, Inc Richmond Virginia 23294 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00104013, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2008 · Synced Sep 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00104013 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →